HealthCap is a Stockholm based venture capital firm investing in life sciences. Founded in 1996, the company is operating globally. As of November 2019, HealthCap raised more than EUR 1 billion and built more than 100 companies.
HealthCap companies have developed more than 20 pharmaceutical products that helps in treating the life-threating medical conditions.
The firm invests in private equity, early stage and late stage. The firm's investment portfolio includes Aprea, Camel-IDS, Carisma Therapeutics, Doctrin, Fusion Pharmaceuticals, InCarda Therapeutics, Modus Therapeutics, Oncorena, and Rainier Therapeutics, etc.
A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases
Altimmune is a therapeutics, treatment, and vaccine development company that looks to find response and prevention solutions
A biopharmaceutical company focused to create products to treat rare and ultra-rare diseases
A biotechnology company focused on the discovery and development of protein therapeutics
A company developing medical devices and technologies to diagnose and treat pulmonary disorders
A biotechnology company developing neo-organs and neo-tissue
A company developing small molecule therapeutics for the treatment of cancer
A company developing HDL therapies to treat cardiovascular and metabolic diseases
A company developing therapies for cardiovascular diseases
Vivet Therapeutics is a France-based company.
Wilson Therapeutics is a Burlington, Massachusetts-based company.
Aro Biotherapeutics is a Philadelphia County, Pennsylvania-based company.
Carisma Therapeutics is a Philadelphia County, Pennsylvania-based company.
BioClin Therapeutics is a San Ramon, California-based company.
Associated investment funds
Documentaries, videos and podcasts